Michael Dickinson

Michael Dickinson

Peter Maccallum Cancer Centre - Melbourne / Australia
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4390073
-
person_outline Michael Dickinson's MOST POPULAR ARTICLES
1-) Axicabtagene ciloleucel as second-line therapy for large B-cell lymphomaFL Locke, DB Miklos, CA Jacobson, MA Perales, MJ Kersten, OO Oluwole, ...New England Journal of Medicine 386 (7), 640-654, 20222442022
2-) Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemiaDS Ritchie, PJ Neeson, A Khot, S Peinert, T Tai, K Tainton, K Chen, ...Molecular Therapy 21 (11), 2122-2129, 20134752013
3-) Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trialF Morschhauser, H Tilly, A Chaidos, P McKay, T Phillips, S Assouline, ...The Lancet Oncology 21 (11), 1433-1442, 20203432020
4-) Second-line tisagenlecleucel or standard care in aggressive B-cell lymphomaMR Bishop, M Dickinson, D Purtill, P Barba, A Santoro, N Hamad, K Kato, ...New England Journal of Medicine 386 (7), 629-639, 20224122022
5-) Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trialNH Fowler, M Dickinson, M Dreyling, J Martinez-Lopez, A Kolstad, ...Nature medicine 28 (2), 325-332, 20223762022